Core Laboratories N.V.CLBNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +7.22% | +0.80% | -4.67% | -0.32% | +0.09% |
| Gross Profit Growth | -3.55% | -27.42% | -3.81% | -4.56% | +8.82% |
| EBITDA Growth | +26.22% | -4.98% | -34.78% | +14.50% | +4.44% |
| Operating Income Growth | +34.97% | -2.79% | -48.47% | -4.48% | +5.68% |
| Net Income Growth | +26.88% | +236.65% | -104.78% | +17.76% | +21.23% |
| EPS Growth | +25.00% | +246.32% | -104.80% | +15.79% | +20.00% |
| EPS Diluted Growth | +31.58% | +220.00% | -104.89% | +15.79% | +20.00% |
| Weighted Average Shares Growth | +0.49% | -0.06% | -0.18% | +1.28% | +0.33% |
| Weighted Average Shares Diluted Growth | +0.45% | +0.45% | -1.95% | -0.49% | -1.55% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +6.10% | +20.43% | -14.17% | -35.08% |
| Free Cash Flow Growth | +0.00% | -3.66% | +24.48% | -29.38% | -47.26% |
| Receivables Growth | +8.99% | +3.48% | +1.12% | -2.13% | -5.59% |
| Inventory Growth | -12.75% | -17.15% | -16.52% | -14.49% | -11.07% |
| Asset Growth | +1.36% | +0.68% | +0.61% | +0.72% | -1.52% |
| Book Value per Share Growth | +11.05% | +12.16% | +9.35% | +7.37% | +7.86% |
| Debt Growth | -14.67% | -16.36% | -15.21% | -11.30% | -14.32% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -8.64% | +9.50% | +15.76% | +2.00% | +28.34% |